Tumour necrosis factor-alpha and tuberculosis: guidance from the National TB Advisory Committee

MeSH terms

• Adalimumab
• Advisory Committees*
• Anti-Inflammatory Agents / administration & dosage*
• Anti-Inflammatory Agents / adverse effects*
• Antibiotic Prophylaxis
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal, Humanized
• Antirheumatic Agents / administration & dosage*
• Antirheumatic Agents / adverse effects*
• Antitubercular Agents / administration & dosage*
• Etanercept
• Humans
• Immune System Diseases / etiology
• Immunoglobulin G / administration & dosage
• Immunoglobulin G / adverse effects
• Infliximab
• Ireland
• Practice Guidelines as Topic*
• Receptors, Tumor Necrosis Factor / administration & dosage
• Tuberculosis / drug therapy
• Tuberculosis / etiology*
• Tuberculosis / prevention & control
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*
• Tumor Necrosis Factor-alpha / physiology*